Get Clay Free →

Nasser Nassiri Koopaei

CEO at EriVan Bio Advancing Exosomes as Targeted Delivery Systems

Nasser Nassiri Koopaei is a leading figure at EriVan Bio, a biotech startup company focusing on the innovative use of exosomes in the medical field.

With a background in PharmD-MPH and Pharmaceutical Engineering, Nasser drives the development projects at EriVan Bio and explores new business opportunities.

He has a strong educational foundation, including a Master's Degree in Pharmaceutical Engineering from the University of Tehran, a PharmD-MPH dual degree from Tehran University of Medical Sciences, and a Ph.D. in Pharmaceutics from the University of Florida.

Nasser has held various roles in prominent organizations like Tamin Pharmaceutical Investment Company, Sobhan Oncology Pharmaceutical Company, and Exir Pharmaceutical Company, showcasing his expertise in business development, R&D, and consultancy within the biopharmaceutical industry.

Through his leadership at EriVan Bio, Nasser aims to meet medical needs by harnessing the potential of exosomes from diverse sources for treating diseases, including cancer, diagnostic purposes, and creating health and beauty products.